ARTICLE | Clinical News
Inhibitex starts Phase II Staph study
March 8, 2001 8:00 AM UTC
Inhibitex (Alpharetta, Ga.) began Phase II testing of its SA- IGIV human immune globulin against Staphylococcus aureus surface antigens to treat S. aureus bacteremia in patients with infectious endoca...